🇺🇸 FDA
Patent

US 9925172

Compounds and methods for treating an epileptic disorder

granted A61KA61K31/137A61K31/19

Quick answer

US patent 9925172 (Compounds and methods for treating an epileptic disorder) held by The Regents of the University of California expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/137, A61K31/19, A61K31/195, A61K31/197